Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
Stock Chart Patterns
Earnings Trading
AI Screener

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ABOS
    4. >
  4. Valuation

Valuation

-
stocks logo
ABOS
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is ABOS Overvalued？

ABOS is now in the zone, suggesting that ABOS current forward PE ratio of -0.75 is considered compare with the five-year average of -8.69.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

ABOS Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
ABOS.O
Acumen Pharmaceuticals Inc
loss
Average P/E: 19.73
-107.35%
88.92M
stocks logo
ORMP.O
Oramed Pharmaceuticals Inc
19.73
Average P/E: 19.73
-502.21%
88.28M
stocks logo
IGMS.O
IGM Biosciences Inc
loss
Average P/E: 19.73
2.66%
93.36M
stocks logo
ASMB.O
Assembly Biosciences Inc
loss
Average P/E: 19.73
54.02%
87.78M
stocks logo
AVTX.O
Avalo Therapeutics Inc
loss
Average P/E: 19.73
89.44%
84.29M
stocks logo
RVPH.O
Reviva Pharmaceuticals Holdings, Inc.
loss
Average P/E: 19.73
48.44%
69.85M

ABOS Revenue Breakdown & PS Ratio Relation

By Business
By Region
Currency:USD
Composition ()
Name
Revenue
Percentage

ABOS FAQs

Is ABOS currently overvalued based on its P/E ratio?

According to the provided data, ABOS's 5-year historical average forward P/E ratio is -8.69. ABOS forward P/E ratio is -0.75, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for ABOS?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

What are the key indicators to watch for ABOS's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

ABOS PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-8.69
Current PE
-0.75
Overvalued PE
6.28
Undervalued PE
-23.66

ABOS EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
-2.72
Current EV
1.24
Overvalued EV
5.33
Undervalued EV
-10.77

ABOS P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
140.46
Current PS
0.00
Overvalued PS
654.16
Undervalued PS
-373.25

ABOS Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
ABOS.O
Acumen Pharmaceuticals Inc
loss
Average P/E: 19.73
-107.35%
88.92M
stocks logo
ORMP.O
Oramed Pharmaceuticals Inc
19.73
Average P/E: 19.73
-502.21%
88.28M
stocks logo
IGMS.O
IGM Biosciences Inc
loss
Average P/E: 19.73
2.66%
93.36M
stocks logo
ASMB.O
Assembly Biosciences Inc
loss
Average P/E: 19.73
54.02%
87.78M
stocks logo
AVTX.O
Avalo Therapeutics Inc
loss
Average P/E: 19.73
89.44%
84.29M
stocks logo
RVPH.O
Reviva Pharmaceuticals Holdings, Inc.
loss
Average P/E: 19.73
48.44%
69.85M

ABOS Revenue Breakdown & PS Ratio Relation

By Business
By Region
Currency:USD
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is ABOS undervalued？Is ABOS overvalued compared to its competitors？

ABOS FAQs

Is ABOS currently overvalued based on its P/E ratio?

According to the provided data, ABOS's 5-year historical average forward P/E ratio is -8.69. ABOS forward P/E ratio is -0.75, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for ABOS?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

What are the key indicators to watch for ABOS's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is ABOS undervalued？Is ABOS overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free